SCHEMBL7540382

SCHEMBL7540382

CCOC(=O)c1c(N)sc2c1CCO2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.59
MAPT P10636 11/20 0.59
HPGD P15428 9/20 0.59
GAA P10253 7/20 0.59
KDM4E B2RXH2 4/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
POLB P06746 1/20 0.59
RECQL P46063 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
HSD17B10 Q99714 4/20 0.58
ALOX15 P16050 3/20 0.58
MAPK1 P28482 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
ADORA1 P30542 3/20 0.53
FHIT P49789 1/20 0.53
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13768569 0.92 ALDH1A1 (0.63) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL8203239 0.79 MAPT (0.72) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL3495630 0.78 MAPT (0.67) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL27558405 0.77 ALDH1A1 (0.43) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL7537079 0.77 ALDH1A1 (0.47) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL7534114 0.77 ALDH1A1 (0.47) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL15200410 0.75 ALDH1A1 (0.46) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL3747531 0.75 ALDH1A1 (0.63) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL13768570 0.75 MAPT (0.67) ALDH1A1MAPTHPGDGAAKDM4E
SCHEMBL223094 0.74 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019412-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-02-14 US disclosed
EP-1080068-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES Novo Nordisk A/S (DK) 2001-03-07 EP disclosed
EP-1062218-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046268-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed
WO-1999046237-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019412-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA ALDH1A1 3737/4885MAPT 475/4885HPGD 2593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.